Page last updated: 2024-10-20

pteridines and HIV

pteridines has been researched along with HIV in 2 studies

HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ram, RR1
Duatschek, P1
Margot, N1
Abram, M1
Geleziunas, R1
Hesselgesser, J1
Callebaut, C1
Tsai, A1
Irrinki, A1
Kaur, J1
Cihlar, T1
Kukolj, G1
Sloan, DD1
Murry, JP1

Other Studies

2 other studies available for pteridines and HIV

ArticleYear
Activation of HIV-specific CD8
    Antiviral therapy, 2020, Volume: 25, Issue:3

    Topics: Anti-HIV Agents; CD8-Positive T-Lymphocytes; Dose-Response Relationship, Drug; Flow Cytometry; HIV;

2020
Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    Journal of virology, 2017, 04-15, Volume: 91, Issue:8

    Topics: Anti-Retroviral Agents; Antibody-Dependent Cell Cytotoxicity; CD8-Positive T-Lymphocytes; Cell Diffe

2017